site stats

Cytk investor relations

WebApr 10, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential... WebApr 4, 2024 · We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold …

Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Can the …

WebMar 31, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in … Cytokinetics to Participate in Upcoming Investor Conferences. link: March 4, … ACC.23 Investor Event: REDWOOD-HCM Cohort 4 & FOREST-HCM 1.1 MB. Apr … Transfer Agent: Computershare 462 South 4th Street Louisville, KY 40202 Phone … Investor FAQ. IR/Media Contacts. Corporate Governance. Information … Investor FAQ. IR/Media Contacts. Corporate Governance. Information … Cytokinetics, Inc. is followed by the analysts listed above. Please note that any … WebMar 15, 2024 · INVESTORS & MEDIA CALENDAR - UPCOMING EVENTS Webcast Barclays Global Healthcare Conference Mar 15, 2024 3:35 PM EDT Webcast Oppenheimer 33rd Annual Healthcare Conference Mar … phoenix college online canvas https://value-betting-strategy.com

Cytokinetics To Participate In The 22nd Annual Needham Virtual ...

WebJul 23, 2024 · SOUTH SAN FRANCISCO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the closing of its previously … WebFeb 22, 2024 · This biopharmaceutical company is expected to post quarterly loss of $1.22 per share in its upcoming report, which represents a year-over-year change of -238.9%. Revenues are expected to be $7.46... WebApr 6, 2024 · Cytokinetics started at overweight with $58 stock price target at J.P. Morgan. Dec. 10, 2024 at 6:59 a.m. ET by Tomi Kilgore. Biotech and Pharma Cytokinetics Stock … phoenix college softball schedule

Cytokinetics Inc CYTK Ownership - NASDAQ Morningstar

Category:Cytokinetics, Incorporated Common Stock (CYTK) - Nasdaq

Tags:Cytk investor relations

Cytk investor relations

Investor Relations Cytek Biosciences

WebJul 19, 2024 · Cytokinetics expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of common stock sold in connection with … WebApr 10, 2024 · Cytokinetics To Participate In The 22nd Annual Needham Virtual Healthcare Conference. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ...

Cytk investor relations

Did you know?

WebApr 10, 2024 · LONDON, April 10, 2024 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,... WebMar 2, 2024 · Cytokinetics, Incorporated ( NASDAQ: CYTK) Q4 2024 Earnings Conference Call March 1, 2024 4:30 PM ET Company Participants Diane Weiser - Senior Vice …

WebMar 22, 2024 · Investors & Media. Cytokinetics, Inc. (NASDAQ: CYTK) is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small … WebJun 17, 2024 · SOUTH SAN FRANCISCO, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that, in response to a request from the U.S. Food and Drug Administration (FDA), the company recently provided additional pharmacokinetic analyses of omecamtiv mecarbil related to the company’s …

WebDec 14, 2024 · CYTK Stock: Focus Back On Aficamten The FDA's experts took issue with the small impact omecamtiv mecarbil had on lowering the risk of death in patients at risk … WebFeb 9, 2024 · As of February 8, 2024, the average one-year price target for Cytokinetics is $63.31. The forecasts range from a low of $47.47 to a high of $84.00. The average price target represents an increase...

WebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) Yahoo. 04/03 16:00. UBS Adjusts Cytokinetics Price Target to $61 From $67, Maintains Buy Rating. MT Newswires. 04/03 10:50. Cantor Fitzgerald Adjusts Price Target on Cytokinetics to $59 From $61, Maintains Overweight Rating. MT Newswires.

WebApr 10, 2024 · CYTK. KK3A. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated ( Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 … how do you cure jock itchWebMar 1, 2024 · Cytokinetics, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.96 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by... phoenix collegiate academy west bromwichWebFind the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. how do you cure high blood pressure naturallyWebSep 28, 2024 · Get the latest Cytokinetics Incorporated (CYTK) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. phoenix collegiate sixth formWebDec 14, 2024 · A "bruising" Food and Drug Administration meeting for Cytokinetics ( CYTK) was actually a blessing in disguise, an analyst said Wednesday as CYTK stock surged. Late Tuesday, a panel of FDA... how do you cure irritable bowel syndromeWeb1 day ago · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … how do you cure lump in throatWebOct 27, 2024 · CYTK stock investors are certainly paying attention. Shares have a strong Relative Strength Rating of 96 out of a best-possible 99, according to IBD Digital. This puts Cytokinetics stock in the... how do you cure low blood pressure